Inventionmed (INM.WA) Stock Price

Inventionmed Price

CLOSED
0.11
​
Market closed

Over the last 12 years Inventionmed grew revenue by 19.6% annually, reaching 3.17 M PLN. Earnings per share have declined at 79.5% per year over the last 4 years. For Inventionmed, the net margin of -23.6% is up versus -6,450.4% a few years ago.

Inventionmed stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inventionmed business model & stock analysis

Inventionmed SA, based in Bydgoszcz, Poland, operates in the Health Care sector, specializing in medical training R&D. The company, listed on 25 March 2013, develops TutorDerm, a VR-based medical simulator for training doctors, medical students, and cosmetologists in dermatological procedures. Its headquarters are located in the Kujawsko-Pomorskie region.

Frequently asked questions about Inventionmed

Converted at the current exchange rate, the Inventionmed share trades at 0.02 EUR (0.11 PLN).

The revenue cannot currently be calculated for Inventionmed.

The profit cannot currently be calculated for Inventionmed.

The P/E ratio cannot be calculated for Inventionmed at the moment.

The P/S cannot be calculated for Inventionmed currently.

The Eulerpool Quality Score for Inventionmed is 6/10.

The ISIN of Inventionmed is PLCDE0000010. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Inventionmed is INM.WA. The ticker symbol is used to trade Inventionmed shares on the stock exchange.

Fair ValueTerminal
0.09 PLN
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Poland
Currency
PLN
Initial public offering
Mar 25, 2013
ISIN
PLCDE0000010
Cusip
X14584100
Market capitalization
22.10 M PLNMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
30.17
P/B Ratio
28.50
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-21.70 %
Last updated Nov 5, 2026, 3:40 AM

Inventionmed Peer Group

Inventionmed FIGI

INM:PW · BBG004752PY7AVCPLN:X2 · BBG00K7MDKW5AVCPLN:XB · BBG00K7MDKX4AVCPLN:XH · BBG00K7MDKZ2AVCPLN:XF · BBG00K7MDL17AVCPLN:XE · BBG00K7MDL35AVCPLN:XJ · BBG00K7MDL44AVCPLN:XL · BBG00K7MDL53AVCPLN:XG · BBG00K7MDL62AVCPLN:XO · BBG00K7MDL71AVCPLN:XS · BBG00K7MDLC5AVCPLN:XA · BBG00K7MDLD4

All fundamentals and in-depth analysis of Inventionmed

Our stock analysis for Inventionmed stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Inventionmed. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.